Development
BioXcel Therapeutics, Inc.
BTAI
$1.84
$0.3120.26%
NASDAQ
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -29.47% | -22.94% | -14.56% | -16.61% | -0.49% |
| Total Receivables | 70.53% | 52.30% | 14.11% | -- | -- |
| Inventory | 4.83% | -1.38% | -1.66% | 40.98% | 0.93% |
| Prepaid Expenses | 4.19% | -17.93% | 46.92% | -44.33% | -34.29% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -53.17% | -7.39% | 30.26% | 58.15% | 43.53% |
| Total Current Assets | -28.57% | -22.02% | -12.62% | -16.05% | -1.33% |
|
|
|||||
| Total Current Assets | -28.57% | -22.02% | -12.62% | -16.05% | -1.33% |
| Net Property, Plant & Equipment | -8.51% | -7.07% | -7.28% | -7.71% | -6.45% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.00% | -90.59% | 0.00% | 0.00% | 0.00% |
| Total Assets | -28.30% | -22.21% | -12.51% | -15.92% | -1.38% |
|
|
|||||
| Total Accounts Payable | -4.77% | 44.70% | -24.31% | 74.18% | -2.47% |
| Total Accrued Expenses | 20.58% | 13.51% | -8.88% | 33.76% | 23.68% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.11% | 2.15% | 1.88% | 2.24% | 1.96% |
| Total Finance Division Other Current Liabilities | 177.36% | -44.56% | 186.23% | -72.58% | 136.05% |
| Total Other Current Liabilities | 177.36% | -44.56% | 186.23% | -72.58% | 136.05% |
| Total Current Liabilities | 13.42% | 20.81% | -12.58% | 40.72% | 16.92% |
|
|
|||||
| Total Current Liabilities | 13.42% | 20.81% | -12.58% | 40.72% | 16.92% |
| Long-Term Debt | 2.32% | 1.88% | 2.16% | 1.48% | 50.14% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -14.26% | -12.23% | -10.56% | -9.45% | -8.54% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 0.05% | -21.29% | 9.86% | 23.90% | -3.22% |
| Total Liabilities | 5.08% | 5.61% | -1.53% | 9.54% | 40.32% |
|
|
|||||
| Common Stock & APIC | 0.77% | 1.23% | 5.94% | 0.95% | 0.95% |
| Retained Earnings | -9.75% | -11.52% | -12.83% | -15.36% | -13.28% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -792.50% | -88.94% | -30.96% | -39.54% | -22.69% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -792.50% | -88.94% | -30.96% | -39.54% | -22.69% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -792.50% | -88.94% | -30.96% | -39.54% | -22.69% |
|
|
|||||